Next investment opportunity will commence around new year 2010. This investment will make it possible to demonstrate that the measurement method applied including algorithms etc. will be at par with current finger-prick devices. Other steps worth mentioning is the clinical testing (planned for  100+ subjects), device developing (mobile unit), software applications and most importantly CE and FDA approval.

If you would like to receive additional information about RSP Systems, please contact RSP Systems at info@rspsystems.com